taurocholic acid has been researched along with Animal Mammary Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SM; Byun, Y; Chung, SW; Jeon, OC; Jin, S; Kim, IS; Kim, SK; Kim, SY; Kim, YS; Lee, E; Lee, M; Moon, HT; Park, RW | 1 |
1 other study(ies) available for taurocholic acid and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Cells, Cultured; Circular Dichroism; Collagen; Drug Combinations; Endothelium, Vascular; Heparin; Heparin, Low-Molecular-Weight; Humans; Laminin; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Peptides; Phosphorylation; Proteoglycans; Taurocholic Acid; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2009 |